We observed decreased DNA promotor methylation of LIFR in BLCA, BRCA, CESC, HNSC, LIHC, LUSC, PRAD, TGCT and UCEC tumor tissues. This evidence concerns the gene LIFR and bladder transitional cell carcinoma.